HNF4G-RSPO2-FUSIONSGEN

Patent europeic · EP3126521 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3126521
Numer da la dumonda
EP15772589
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
03-04-2015
Publitgà
08-02-2017
Concedì
20-03-2019
La protecziun finescha il pli tard
02-04-2035
Proxima taxa annuala scadenta
30-04-2027
Classas IPC
C12Q 1/6886 (2018.01)
Prioritad
CN 201410135569 04.04.2014
Dumonda PCT
PCT/CN2015/075882 03.04.2015
Publicaziun PCT
WO2015/149720 08.10.2015
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-05-2026

    Midada

    Published in Swissreg on 01.05.2026

  2. 01-05-2025

    Midada

    Published in Swissreg on 01.05.2025

  3. 01-05-2024

    Midada

    Published in Swissreg on 01.05.2024

  4. 01-05-2023

    Midada

    Published in Swissreg on 01.05.2023

  5. 20-03-2019

    Concedì

    Published in Swissreg on 20.03.2019

Partidas

Possessur

Crown Bioscience, Inc. (Taicang)

6 Beijing West Road Science and Technology Park Taicang Economie Development Area, Jiangsu 215400, CN

Represchentant

Roman VUILLE

1196 GLAND

Inventur

CAI, Jie

Jiangsu 215400, CN

LI, Henry

Jiangsu 215400, CN

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.